Suppliers / Shandong Sirui Pharmaceutical

Shandong Sirui Pharmaceutical

China Updated 9 July 2026

Shandong Sirui Pharmaceutical is an API manufacturer based in China. It holds 4 active US drug master files and 8 valid CEPs across a filed portfolio of 9 molecules.

4
active US DMFs
8
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Heze, China Not on file

What they file, and where

Molecule Regulators Docs
Dexamethasone EDQM, US FDA 3
Fluticasone Propionate EDQM, US FDA 2
Abiraterone US FDA 1
Betamethasone EDQM 1
Fluticasone Furoate EDQM 1
Methylprednisolone EDQM 1
Mometasone Furoate EDQM 1
Triamcinolone US FDA 1
Triamcinolone Acetonide EDQM 1

Also appears on these molecule pages

Comparing suppliers?

Choose your molecules and target markets. Shandong Sirui Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability